Mast cell activation induced by tamoxifen citrate via MRGPRX2 plays a potential adverse role in breast cancer treatment.

• Tác giả: Jiapan Gao, Jiming Jin, Panpan Lei, Weina Ma, Xiaoyu Ma, Bingxi Ren, Xinyue Su, Yuxiu Zhang
• Ngôn ngữ: eng
• Ký hiệu phân loại: 553.453 Tin
• Thông tin xuất bản: England : Biochemical pharmacology , 2025
• Bộ sưu tập: NCBI
• ID: 641917

Tóm tắt

Breast cancer is the most common malignant tumor endangering women's life and health. Tamoxifen citrate (TAM) is the first-line drug of adjuvant endocrine therapy for estrogen receptor-positive (ER